Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort

Saved in:
Bibliographic Details
Published in:View
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870116622589493248
collection WordPress RSS
FRELIP Feed Integration
container_title View
description
discipline_display Biology
discipline_facet Biology
format Online Article
RSS Article
genre Journal Article
id rss_article:100806
institution FRELIP
journal_source_facet View
last_indexed 2026-07-08T03:43:11.300Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
Biology
General
Biology
sub_discipline_display General
sub_discipline_facet General
subject_display Biology
General
Biology
subject_facet Biology
General
Biology
title Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
title_alt Beneficio de supervivencia y evaluación de seguridad de la suplementación con probióticos en pacientes infectados con ómicron: evidencia del mundo real de una cohorte multicéntrica de 12,615 pacientes
Bénéfice de survie et évaluation de la sécurité de la supplémentation probiotique chez les patients infectés par Omicron : données réelles d'une cohorte multicentrique de 12 615 patients
Benefício de sobrevivência e avaliação de segurança da suplementação probiótica em pacientes infectados por ômicron: Evidências do mundo real de uma coorte multicêntrica de 12.615 pacientes
title_auth Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
title_es_txt Beneficio de supervivencia y evaluación de seguridad de la suplementación con probióticos en pacientes infectados con ómicron: evidencia del mundo real de una cohorte multicéntrica de 12,615 pacientes
title_fr_txt Bénéfice de survie et évaluation de la sécurité de la supplémentation probiotique chez les patients infectés par Omicron : données réelles d'une cohorte multicentrique de 12 615 patients
title_full Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
title_fullStr Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
title_full_unstemmed Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
title_pt_txt Benefício de sobrevivência e avaliação de segurança da suplementação probiótica em pacientes infectados por ômicron: Evidências do mundo real de uma coorte multicêntrica de 12.615 pacientes
title_short Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort
title_sort survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: real‐world evidence from a multicenter 12,615‐patient cohort
topic Biology
General
Biology
url https://onlinelibrary.wiley.com/doi/10.1002/VIW.20250074?af=R